DexCom Inc (DXCM) stock
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3030% below fair value
$83.33+1.94 (+2.38%)
Close on Nov 13, 2026Market cap $31.08BP/E 32.8Yield –
DexCom operating margin
Operating margin is operating income as a percentage of revenue.
DexCom's operating margin for the twelve months ending Sep 30, 2026 was 24.0%. For fiscal 2025 it was 19.6%, against 14.9% the year before. The highest annual figure on record is 19.6% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 19.6% | +4.7 |
| FY2024 | Dec 31, 2024 | 14.9% | −1.6 |
| FY2023 | Dec 31, 2023 | 16.5% | +3.1 |
| FY2022 | Dec 31, 2022 | 13.4% | +2.6 |
| FY2021 | Dec 31, 2021 | 10.9% | −4.7 |
| FY2020 | Dec 31, 2020 | 15.5% | +5.9 |
| FY2019 | Dec 31, 2019 | 9.6% | +27.7 |
| FY2018 | Dec 31, 2018 | -18.1% | −12.1 |
| FY2017 | Dec 31, 2017 | -5.9% | +5.2 |
| FY2016 | Dec 31, 2016 | -11.1% | +3.1 |
| FY2015 | Dec 31, 2015 | -14.2% | −5.9 |
| FY2014 | Dec 31, 2014 | -8.3% | +9.8 |
| FY2013 | Dec 31, 2013 | -18.1% | +37.7 |
| FY2012 | Dec 31, 2012 | -55.8% | +3.0 |
| FY2011 | Dec 31, 2011 | -58.7% | +34.5 |
| FY2010 | Dec 31, 2010 | -93.2% | +61.1 |
| FY2009 | Dec 31, 2009 | -154.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 24.3% | +4.3 |
| Q2 FY2026 | Jun 30, 2026 | 24.3% | +6.0 |
| Q1 FY2026 | Mar 31, 2026 | 21.4% | +8.5 |
| Q4 FY2025 | Dec 31, 2025 | 25.6% | +8.7 |
| Q3 FY2025 | Sep 30, 2025 | 20.1% | +4.8 |
| Q2 FY2025 | Jun 30, 2025 | 18.4% | +2.6 |
| Q1 FY2025 | Mar 31, 2025 | 12.9% | +1.9 |
| Q4 FY2024 | Dec 31, 2024 | 17.0% | −4.0 |
| Q3 FY2024 | Sep 30, 2024 | 15.3% | −5.8 |
| Q2 FY2024 | Jun 30, 2024 | 15.7% | +1.0 |
| Q1 FY2024 | Mar 31, 2024 | 11.0% | +4.6 |
| Q4 FY2023 | Dec 31, 2023 | 21.0% | +5.6 |
| Q3 FY2023 | Sep 30, 2023 | 21.1% | +1.9 |
| Q2 FY2023 | Jun 30, 2023 | 14.7% | +3.6 |
| Q1 FY2023 | Mar 31, 2023 | 6.4% | −0.2 |
| Q4 FY2022 | Dec 31, 2022 | 15.4% | +15.3 |
| Q3 FY2022 | Sep 30, 2022 | 19.2% | +1.0 |
| Q2 FY2022 | Jun 30, 2022 | 11.1% | −5.9 |
| Q1 FY2022 | Mar 31, 2022 | 6.6% | −2.5 |
| Q4 FY2021 | Dec 31, 2021 | 0.1% | −18.2 |
| Q3 FY2021 | Sep 30, 2021 | 18.2% | −0.6 |
| Q2 FY2021 | Jun 30, 2021 | 17.0% | +2.0 |
| Q1 FY2021 | Mar 31, 2021 | 9.1% | +0.8 |
| Q4 FY2020 | Dec 31, 2020 | 18.3% | −3.7 |
| Q3 FY2020 | Sep 30, 2020 | 18.8% | +4.7 |
| Q2 FY2020 | Jun 30, 2020 | 15.0% | +15.2 |
| Q1 FY2020 | Mar 31, 2020 | 8.3% | +13.4 |
| Q4 FY2019 | Dec 31, 2019 | 21.9% | +70.6 |
| Q3 FY2019 | Sep 30, 2019 | 14.1% | +8.9 |
| Q2 FY2019 | Jun 30, 2019 | -0.2% | +1.8 |
| Q1 FY2019 | Mar 31, 2019 | -5.1% | +11.5 |
| Q4 FY2018 | Dec 31, 2018 | -48.7% | −54.1 |
| Q3 FY2018 | Sep 30, 2018 | 5.2% | +5.5 |
| Q2 FY2018 | Jun 30, 2018 | -2.0% | +6.0 |
| Q1 FY2018 | Mar 31, 2018 | -16.6% | +11.7 |
| Q4 FY2017 | Dec 31, 2017 | 5.4% | +9.0 |
| Q3 FY2017 | Sep 30, 2017 | -0.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -8.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -28.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -3.6% | – |
See a number that looks wrong?